|
Real-time
Euronext Paris
11:56:04 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 165.10 EUR | 0.00% |
|
+4.83% | +38.74% |
| 08-17 | Kepler Cheuvreux Boosts Ipsen PT, Maintains Hold Rating | MT |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 15.78B | |||||
| 1,141B | |||||
| 659B | - | - | - | ||
| 470B | |||||
| 366B | |||||
| 302B |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
